Salomon & Ludwin’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$81.3K Buy
1,697
+1,075
+173% +$50.1K 0.01% 303
2025
Q4
$29.6K Sell
622
-146
-19% -$7.24K ﹤0.01% 621
2025
Q3
$39.1K Buy
768
+701
+1,046% +$33.8K ﹤0.01% 449
2025
Q2
$3.3K Buy
67
+27
+68% +$1.38K ﹤0.01% 604
2025
Q1
$2.22K Hold
40
﹤0.01% 581
2024
Q4
$1.93K Hold
40
﹤0.01% 597
2024
Q3
$2.31K Hold
40
﹤0.01% 602
2024
Q2
$1.94K Sell
40
-79
-66% -$3.81K ﹤0.01% 609
2024
Q1
$5.78K Hold
119
﹤0.01% 615
2023
Q4
$6.38K Hold
119
﹤0.01% 553
2023
Q3
$6.38K Buy
+119
New +$6.34K ﹤0.01% 551

Other funds holding SNY

Salomon & Ludwin's SNY Position: Q1 2026 in Review

Salomon & Ludwin increased its Sanofi (SNY) stake by 173% in Q1 2026, buying an estimated $50.1K and bringing the position to 1,697 shares worth $81.3K. The position accounts for 0.01% of the portfolio, ranked #303.

Salomon & Ludwin first reported a position in SNY in Q3 2023 and has held it in 11 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Salomon & Ludwin held 1,697 shares of Sanofi worth $81.3K as of Q1 2026.
  • Salomon & Ludwin bought 1,075 Sanofi shares in Q1 2026, an estimated $50.1K.
  • Sanofi made up 0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #303 holding.
  • Salomon & Ludwin first reported a position in Sanofi in Q3 2023 and has held it in 11 quarters since.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.